At the time of writing, MaxCyte Inc [MXCT] stock is trading at $3.88, up 0.52%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
MaxCyte Inc [NASDAQ: MXCT] stock has seen the most recent analyst activity on November 29, 2023, when Craig Hallum initiated its Buy rating and assigned the stock a price target of $7. On August 24, 2021, William Blair initiated with a Outperform rating. Wedbush started tracking the stock assigning a Outperform rating and suggested a price target of $36 on August 24, 2021. Stifel initiated its recommendation with a Buy and recommended $18 as its price target on August 24, 2021. Stephens started tracking with a Overweight rating for this stock on August 24, 2021, and assigned it a price target of $19. In a note dated August 24, 2021, Cowen initiated an Outperform rating.
For the past year, the stock price of MaxCyte Inc fluctuated between $3.15 and $5.55. Currently, Wall Street analysts expect the stock to reach $8 within the next 12 months. MaxCyte Inc [NASDAQ: MXCT] shares were valued at $3.88 at the most recent close of the market. An investor can expect a potential return of 106.19% based on the average MXCT price forecast.
Analyzing the MXCT fundamentals
According to MaxCyte Inc [NASDAQ:MXCT], the company’s sales were 45.44M for trailing twelve months, which represents an 15.33% jump. Gross Profit Margin for this corporation currently stands at 0.81% with Operating Profit Margin at -1.02%, Pretax Profit Margin comes in at -0.78%, and Net Profit Margin reading is -0.78%. To continue investigating profitability, this company’s Return on Assets is posted at -0.14, Equity is -0.16 and Total Capital is -0.19. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.73 points at the first support level, and at 3.59 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.09, and for the 2nd resistance point, it is at 4.30.
Ratios To Look Out For
It is important to note that MaxCyte Inc [NASDAQ:MXCT] has a current ratio of 14.31. In addition, the Quick Ratio stands at 13.40 and the Cash Ratio stands at 3.06. Considering the valuation of this stock, the price to sales ratio is 8.97, the price to book ratio is 1.84.
Transactions by insiders
Recent insider trading involved Erck Stanley C, Director, that happened on Nov 01 ’24 when 47689.0 shares were sold. Director, Johnston John Joseph completed a deal on Oct 28 ’24 to sell 3000.0 shares. Meanwhile, Director Erck Stanley C sold 26082.0 shares on Oct 01 ’24.
